Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
33.08%
Grew
—
—
Shrank
—
1 Year
Score—
Net Growth33.08%
Net TrendGrew
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
-43.71%
40%
—
—
20%
—
5 Years
Score—
Net Growth-43.71%
Net Trend40%
Net Income Consistency—
Rev Growth—
Rev Trend20%
Revenue Consistency—
Kezar Life Sciences Inc fundamental performance
Across Kezar Life Sciences Inc's full reported history, from 2018 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 23M to -$ 56M. Revenue increased in 14% of the years measured; net income in 29%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 0.17 | — |
1 Year2025-08-12 | $ 3.90 | -95.51% |
5 Years2021-08-12 | $ 58.50 | -99.70% |
All Time2018-06-21 | $ 177.50 | -99.90% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2018-06-21 |
|---|---|---|---|---|
| Price | $ 0.17 | $ 3.90 | $ 58.50 | $ 177.50 |
| Return | — | -95.51% | -99.70% | -99.90% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 0.00 | -$ 56M | $ 71M |
| 2024 | $ 0.00 | -$ 83M | $ 132M |
| 2023 | $ 7M | -$ 101M | $ 201M |
| 2022 | $ 0.00 | -$ 65M | $ 276M |
| 2021 | $ 0.00 | -$ 54M | $ 208M |
| 2020 | $ 0.00 | -$ 38M | $ 140M |
| 2019 | $ 0.00 | -$ 31M | $ 78M |
| IPO2018 | $ 0.00 | -$ 23M | $ 107M |
Explore beyond KZR
You're looking at Kezar Life Sciences Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
